FDA approval of 2-drug injectable Cabenuva is a game changer in maintaining viral suppression in patients.
Artificial intelligence holds immense potential to address the rising demand for oncology services and improve patient outcomes by facilitating more effective, efficient, personalized cancer care.
In an ambitious effort to address the ongoing uncertainty within the 340B Program space, 6 senators released a draft discussion bill earlier this year titled the SUSTAIN Act.
Low compensation, stressful environment spark technician exodus; replacing them has been difficult.
Environmental conditions and air pollution affect health by causing injuries and fatalities, exacerbating respiratory and cardiovascular diseases, and spreading infectious diseases.
Ambulatory infusion centers can help reduce the cost of care for payers and patients and allow pharmacists to contribute to a positive treatment experience.
Patients and other stakeholders need to be able to compare pharmacies based on standardized, transparent metrics with a measurement system to make informed decisions.
The agency is looking to regulate them as medical devices.
Five medications (tramadol, olanzapine, mirtazapine, bupropion, and atomoxetine) were associated with significantly better OUD remission.
In most patients who are pregnant or may become pregnant, warfarin is contraindicated due to increased risk of adverse fetal outcomes.
Pharmacists dispensing Lybalvi should understand that potentially life-threatening consequences can occur if opioids are taken concurrently.
Chicago Tribune investigation on pharmacists’ time and workload sparks new regulations.
Strong support from pharmacy professionals and a shift in systems and workflows help pave the way for success.
FDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.
CMS Interim Final Rule on mandatory COVID-19 vaccinations for all facilities participating in Medicare and Medicaid potentially impacts pharmacies that provide services under a contract or arrangement with these facilities.
Having community pharmacists to influence outcomes associated with social determinants of health in the US population is vital to improving overall patient outcomes.
Building a team to support best practices, medication safety, and staff education can reduce risks.
Vanderbilt Specialty Pharmacy and Takeda Oncology are reaching across silos and entering an innovative partnership to improve patient care across the entire medication journey.
Students are being exposed to new patient experiences through collaboration with practitioners.
In patients already using analgesics for pain control, pharmacists need to address medication adherence for improved osteoarthritis symptom control.
The prevalence of hypertension continues to increase amongst adults in the United States, leading to other cardiovascular conditions. Lifestyle changes and medication adherence are essential for appropriate hypertension management.
The risk of therapy duplication with OTC and prescription PPIs can be lowered with an innovative, multi-faceted, and intentional approach by pharmacy teams and prescribers.
High adherence to treatment is a key first step toward better patient outcomes, including sustained disease control or remission.
In recent years, pharmacist roles have evolved as critically important caregivers who increasingly provide essential health care services far beyond medication dispensing.
Nuances can lead to frequent areas of confusion.
Pharmacy workflow changes in the preparation of chemotherapy products can reduce patient chair time.
To build a brighter, healthier, and more equitable future for all US citizens, there is an indisputable need to decriminalize psychedelic medicines.
Treatment options are distinct in their mechanisms, safety profiles, and implications for patients’ quality of life.